celecoxib has been researched along with Dermatitis Medicamentosa in 33 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 55-year-old woman who was treated for periarthritis humeroscapularis with celecoxib (Celebrex) developed a generalized pustular exanthema on the head and upper trunk, accompanied by fever, leukocytosis and increased erythrocyte sedimentation rate." | 8.82 | Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. ( Braathen, LR; Goeschke, B, 2004) |
| "Acute generalized exanthematous pustulosis (AGEP) is a rapidly evolving, febrile, widespread, non-follicular pustular eruption mainly provoked by drugs." | 5.32 | Acute generalized exanthematous pustulosis caused by celecoxib. ( Chen, WC; Lee, JY; Yang, CC, 2004) |
| "A 55-year-old woman who was treated for periarthritis humeroscapularis with celecoxib (Celebrex) developed a generalized pustular exanthema on the head and upper trunk, accompanied by fever, leukocytosis and increased erythrocyte sedimentation rate." | 4.82 | Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. ( Braathen, LR; Goeschke, B, 2004) |
| " Phone call follow up in 25 patients disclosed that 15 patients continued to take celecoxib, while five patients did not take celecoxib following the oral challenge, and five discontinued celecoxib due to adverse effects, lack of drug efficacy or physician preference." | 2.71 | Safety of celecoxib in individuals allergic to sulfonamide: a pilot study. ( Knowles, SR; Neuman, MG; Shapiro, LE; Shear, NH; Weber, E, 2003) |
| "Celecoxib (CE) is a novel drug, with high selectivity and affinity for COX-2 enzyme." | 2.71 | Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs. ( D'Amato, G; D'Amato, M; Liccardi, G; Piccolo, A; Piscitelli, E; Salzillo, A; Senna, G, 2005) |
| "Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) which acts via specific inhibition of cyclooxygenase-2 (synthesis of prostaglandins mediating pathological inflammation) but which preserves the homeostatic action of cyclooxygenase-1." | 1.32 | [Hypersensitivity to celecoxib]. ( Chiffoleau, A; Fradet, G; Huguenin, H; Robin-Le Nechet, A, 2003) |
| "Celecoxib (Celebrex) is a Cox 2 selective non steroidal anti-inflammatory agent." | 1.32 | [Severe cutaneous drug reactions to celecoxib (Celebrex)]. ( Barbarot, S; Cassagnau, E; Foulc, P; Marquès, S; Milpied, B; Stalder, JF, 2003) |
| "Celecoxib is a new generation non-steroidal anti-inflammatory drug and sulfonamide derivative." | 1.32 | Celecoxib-induced photoallergic drug eruption. ( Baz, K; Ikizoglu, G; Kokturk, A; Tataroglu, C; Uzumlu, H; Yazici, AC, 2004) |
| "Acute generalized exanthematous pustulosis (AGEP) is a rapidly evolving, febrile, widespread, non-follicular pustular eruption mainly provoked by drugs." | 1.32 | Acute generalized exanthematous pustulosis caused by celecoxib. ( Chen, WC; Lee, JY; Yang, CC, 2004) |
| "Celecoxib is a new cyclo-oxygenase-2 inhibitor recently approved for arthritis." | 1.31 | Celecoxib-induced Sweet's syndrome. ( Berger, TG; Connolly, MK; Crowley, E; Fye, KH; LeBoit, PE, 2001) |
| "Celecoxib (Celebrex(R)) is a new generation non-steroidal anti-inflammatory drug, recently introduced in France." | 1.31 | [Celecoxib induced toxiderma with positive patch-test]. ( Ajebbar, K; Caron, J; Charlanne, H; Modiano, P; Morant, C; Verbeiren, S, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 24 (72.73) | 29.6817 |
| 2010's | 7 (21.21) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, R | 1 |
| Cheo, FF | 1 |
| Lee, HY | 1 |
| Miroux-Catarino, A | 1 |
| Silva, L | 1 |
| Amaro, C | 1 |
| Ferreira, ML | 1 |
| Viana, I | 1 |
| Ammar, H | 1 |
| Ben Fredj, N | 1 |
| Ben Fadhel, N | 1 |
| Chadli, Z | 1 |
| Ben Romdhane, H | 1 |
| Boughattas, NA | 1 |
| Chaabane, A | 1 |
| Aouam, K | 1 |
| Gómez de la Fuente, E | 1 |
| Pampín Franco, A | 1 |
| Caro Gutiérrez, D | 1 |
| López Estebaranz, JL | 1 |
| Ueno, M | 1 |
| Namiki, T | 1 |
| Inui, K | 1 |
| Hanafusa, T | 1 |
| Miura, K | 1 |
| Yokozeki, H | 1 |
| Lee, JH | 1 |
| Park, HK | 1 |
| Heo, J | 1 |
| Kim, TO | 1 |
| Kim, GH | 1 |
| Kang, DH | 1 |
| Song, GA | 1 |
| Cho, M | 1 |
| Kim, DS | 1 |
| Kim, HW | 1 |
| Lee, CH | 1 |
| Gordon, PH | 1 |
| Cheung, YK | 1 |
| Levin, B | 1 |
| Andrews, H | 1 |
| Doorish, C | 1 |
| Macarthur, RB | 1 |
| Montes, J | 1 |
| Bednarz, K | 1 |
| Florence, J | 1 |
| Rowin, J | 1 |
| Boylan, K | 1 |
| Mozaffar, T | 1 |
| Tandan, R | 1 |
| Mitsumoto, H | 1 |
| Kelvin, EA | 1 |
| Chapin, J | 1 |
| Bedlack, R | 1 |
| Rivner, M | 1 |
| McCluskey, LF | 1 |
| Pestronk, A | 1 |
| Graves, M | 1 |
| Sorenson, EJ | 1 |
| Barohn, RJ | 1 |
| Belsh, JM | 1 |
| Lou, JS | 1 |
| Levine, T | 1 |
| Saperstein, D | 1 |
| Miller, RG | 1 |
| Scelsa, SN | 1 |
| Cimbollek, S | 1 |
| Quiralte, J | 1 |
| Avila, R | 1 |
| Kasemsarn, P | 1 |
| Kulthanan, K | 1 |
| Tuchinda, P | 1 |
| Dhana, N | 1 |
| Jongjarearnprasert, K | 1 |
| Arakawa, Y | 1 |
| Nakai, N | 1 |
| Katoh, N | 1 |
| Ponce, V | 1 |
| Muñoz-Bellido, F | 1 |
| Moreno, E | 1 |
| Laffond, E | 1 |
| González, A | 1 |
| Dávila, I | 1 |
| Gscheidel, D | 1 |
| Daspet, MK | 1 |
| Le Coz, CJ | 1 |
| Lipsker, D | 1 |
| Jordan, KM | 1 |
| Edwards, CJ | 1 |
| Arden, NK | 1 |
| Shapiro, LE | 1 |
| Knowles, SR | 1 |
| Weber, E | 1 |
| Neuman, MG | 1 |
| Shear, NH | 1 |
| Giglio, P | 1 |
| Bandyopadhyay, D | 1 |
| Fradet, G | 1 |
| Robin-Le Nechet, A | 1 |
| Huguenin, H | 1 |
| Chiffoleau, A | 1 |
| Valero, A | 1 |
| Enrique, E | 2 |
| Baltasar, M | 1 |
| Cisteró, A | 1 |
| Martí, E | 1 |
| Picado, C | 1 |
| Zembowicz, A | 1 |
| Mastalerz, L | 1 |
| Setkowicz, M | 1 |
| Radziszewski, W | 1 |
| Szczeklik, A | 1 |
| Rodríguez, M | 1 |
| Castello, JV | 1 |
| de Mateo, JA | 1 |
| Roca, B | 1 |
| Malek, T | 1 |
| Marquès, S | 1 |
| Milpied, B | 1 |
| Foulc, P | 1 |
| Barbarot, S | 1 |
| Cassagnau, E | 1 |
| Stalder, JF | 1 |
| Alonso, JC | 1 |
| Ortega, JD | 1 |
| Gonzalo, MJ | 1 |
| Yazici, AC | 1 |
| Baz, K | 1 |
| Ikizoglu, G | 1 |
| Kokturk, A | 1 |
| Uzumlu, H | 1 |
| Tataroglu, C | 1 |
| Goeschke, B | 1 |
| Braathen, LR | 1 |
| Yang, CC | 1 |
| Lee, JY | 1 |
| Chen, WC | 1 |
| Drago, F | 1 |
| Brusati, C | 1 |
| Desirello, G | 1 |
| Cacciapuoti, M | 1 |
| Rebora, A | 1 |
| Liccardi, G | 1 |
| Salzillo, A | 1 |
| Piccolo, A | 1 |
| Senna, G | 1 |
| Piscitelli, E | 1 |
| D'Amato, M | 1 |
| D'Amato, G | 1 |
| Schmutz, JL | 1 |
| Barbaud, A | 1 |
| Trechot, P | 1 |
| Patterson, R | 1 |
| Bello, AE | 1 |
| Lefkowith, J | 1 |
| Grob, M | 1 |
| Scheidegger, P | 1 |
| Wüthrich, B | 1 |
| Fye, KH | 1 |
| Crowley, E | 1 |
| Berger, TG | 1 |
| LeBoit, PE | 1 |
| Connolly, MK | 1 |
| Habki, R | 1 |
| Vermeulen, C | 1 |
| Bachmeyer, C | 1 |
| Charoud, A | 1 |
| Mofredj, A | 1 |
| Verbeiren, S | 1 |
| Morant, C | 1 |
| Charlanne, H | 1 |
| Ajebbar, K | 1 |
| Caron, J | 1 |
| Modiano, P | 1 |
4 reviews available for celecoxib and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Celecoxib-induced erythema multiforme-type drug eruption with a positive patch test.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug E | 2011 |
Allergic vasculitis associated with celecoxib.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Drug Eruptions; | 2002 |
Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far.
Topics: Arm; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Diagnosis, Differential; Drug Eruptions; Exant | 2004 |
Immunologic tolerability profile of celecoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Clinical Trials as Topic; Cross Reactions; Cyclo | 1999 |
5 trials available for celecoxib and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Celecoxib; Creatine; Double-Blind Met | 2008 |
Safety of celecoxib in individuals allergic to sulfonamide: a pilot study.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Celecoxib; Cross Reactions; Cyclooxygenase | 2003 |
[Celecoxib in NSAID-induced cutaneous and respiratory adverse reactions].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Drug Eru | 2003 |
Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Celecoxib; Comput | 2003 |
Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
Topics: Acetaminophen; Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecox | 2005 |
24 other studies available for celecoxib and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Celecoxib and Bullous Symmetrical Drug-Related Intertriginous and Flexural Exanthem (SDRIFE).
Topics: Celecoxib; Drug Eruptions; Exanthema; Humans | 2023 |
Bullous fixed drug eruption induced by etoricoxib, confirmed by patch testing, with tolerance to celecoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Blister; Celecoxib; Drug Eruptions; Etoricoxib; | 2019 |
Celecoxib-induced bullous fixed drug eruption: An unusual presentation.
Topics: Adult; Celecoxib; Chin; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Dysmenorrhea; Female; Humans; N | 2019 |
Fixed drug eruption due to etoricoxib in a patient with tolerance to celecoxib: the value of patch testing.
Topics: Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Etoricoxib; Female; Humans; Patch Tes | 2014 |
Neutrophilic panniculitis with vasculitis in a melanoma patient treated with vemurafenib: a case report and its management.
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antineoplast | 2017 |
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Arthritis; Celecoxib; Drug Er | 2008 |
COX-2 inhibitors in patients with sensitivity to nonselective NSAIDs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug E | 2009 |
Cutaneous reactions to non-steroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Cel | 2011 |
Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib.
Topics: Aged; Arm; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Etoricoxib; Female; Humans; Isoxa | 2012 |
[Allergic vasculitis following ingestion of celecoxib?].
Topics: Administration, Oral; Aged; Celecoxib; Cyclooxygenase Inhibitors; Diagnosis, Differential; Drug Erup | 2002 |
Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
Topics: Celecoxib; Cyclooxygenase Inhibitors; Drug Eruptions; Humans; Pyrazoles; Stevens-Johnson Syndrome; S | 2003 |
Celecoxib-induced fixed drug eruption.
Topics: Administration, Topical; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthriti | 2003 |
[Hypersensitivity to celecoxib].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chemical and Drug Induced Liver Injury; Dr | 2003 |
Tolerability of cyclooxygenase 2 inhibitors and the advisability of oral challenge.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; | 2003 |
[Severe cutaneous drug reactions to celecoxib (Celebrex)].
Topics: Aged; Celecoxib; Cyclooxygenase Inhibitors; Drug Eruptions; Female; Humans; Male; Pyrazoles; Severit | 2003 |
Cutaneous reaction to oral celecoxib with positive patch test.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Eruptions; Fema | 2004 |
Celecoxib-induced photoallergic drug eruption.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Brachial Plexus Neuritis; Celecoxib; Dermatitis, Photoaller | 2004 |
Acute generalized exanthematous pustulosis caused by celecoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Eruptions; Exanthema; Female; Humans; Middl | 2004 |
Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
Topics: Aged; Celecoxib; Cyclooxygenase Inhibitors; Drug Eruptions; Female; Humans; Lactones; Male; Middle A | 2004 |
[Pseudoporphyria and coxib].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Celecoxib; Cyclooxygenase Inhibitors; Diagnosis, Di | 2006 |
Allergic skin reaction to celecoxib.
Topics: Aged; Celecoxib; Cyclooxygenase Inhibitors; Drug Eruptions; Female; Humans; Male; Middle Aged; Osteo | 2000 |
Celecoxib-induced Sweet's syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Drug Eruptions; Human | 2001 |
[Anaphylactic shock induced by celecoxib].
Topics: Anaphylaxis; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Erup | 2001 |
[Celecoxib induced toxiderma with positive patch-test].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Eruptions; Humans; Male; Pyrazoles; | 2002 |